Author:
Li Min,Shi Aixin,Pang Hongxian,Xue Wei,Li Yang,Cao Guoying,Yan Bei,Dong Fan,Li Kexin,Xiao Wei,He Guorong,Du Guanhua,Hu Xin
Funder
Kanion pharmaceutical Limited Corporation
Subject
Drug Discovery,Pharmacology
Reference29 articles.
1. Different effects of baicalein, baicalin and wogonin on mitochondrial function, glutathione content and cell cycle progression in human hepatoma cell lines;Chang;Planta Medica,2002
2. Neuroprotective effect of baicalein against MPTP neurotoxicity: behavioral, biochemical and immunohistochemical profile;Cheng;Neuroscience Letters,2008
3. Parkinson׳s disease: mechanisms and models;Dauer;Neuron,2003
4. Du, G.H., Lv, Y., Chang, Y., Cheng, Y.X., He, G.R., Pei, L.X. Two crystal substances of baicalin, and preparations, pharmaceutical composition and uses thereof. Chinese Patent no. CN101434593 B; 2013.
5. Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers;Food and Drug Administration,2005
Cited by
128 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献